DP3 Type 1 Diabetes Targeted Research Award
Type 1 Diabetes Complications IMPACT Award (DP3)
This FOA encourages research applications from institutions/organizations proposing innovative studies focused on major obstacles to developing therapeutic approaches for complications of Type 1 Diabetes.
|Notice(s) for this Opportunity|
|Letter of Intent Due Date|
|Application Due Date|
March 19, 2015, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.